本月全球药品研发进展取得成效的药物有34个,较上月大幅减少了1 3个,除注册前阶段的略有增加外,其它各研发阶段的药品数量均下降显著。进入注册阶段的有16个,比上月大幅减少14个。其中6个为全球首次注册的新活性物质、新制剂和新适应证,其余10个均为在新市场补充注册。 There were 34 drugs that made progress in global drug development this month, a sharp decrease of 13 from the previous month. The number of drugs in other R & D phases declined significantly except for a slight increase in pre-registration phase. There were 16 entries in the registration phase, a sharp decrease of 14 from the previous month. Six of these were the first new active substances, new preparations and new indications registered in the world, and the remaining 10 were newly registered in the new markets.